Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€11.95

€11.95

-9.820%
-1.3
-9.820%
€17.59
 
17.05.24 / Tradegate WKN: A2PKMZ / Symbol: NVAX / Name: Novavax / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Novavax Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Novavax

sharewise wants to provide you with the best news and tools for Novavax, so we directly link to the best financial data sources.

News

Is Novavax Stock a Buy?: https://g.foolcdn.com/editorial/images/777000/a-couple-making-financial-decisions-with-the-help-of-a-laptop-and-calculator.jpg
Is Novavax Stock a Buy?

Novavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are up 200% since the start of May

If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now: https://g.foolcdn.com/editorial/images/777505/gettyimages-519517489-1.jpg
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now

If you'd invested $10,000 in Novavax (NASDAQ: NVAX) a year ago, you would have made a risky bet. That's because the biotech company had issued a going concern earlier this year. This warning meant

1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?: https://g.foolcdn.com/editorial/images/777258/person-about-to-receive-a-vaccine-shot.jpg
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?

Novavax (NASDAQ: NVAX) took a turn in the investor spotlight in early May, when the vaccine specialist announced -- on the same day it unveiled its first-quarter results -- a collaboration deal with

2 Incredible Growth Stocks to Buy Hand Over Fist Right Now: https://g.foolcdn.com/editorial/images/777269/growth-stock.jpg
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

Despite some turbulence, growth stocks have been on a bull run since the 2008 financial crisis. Groundbreaking innovations in technology and healthcare have been the primary drivers behind this

Novavax Stock Just Tripled. Is It Too Late to Buy?: https://g.foolcdn.com/editorial/images/777293/gettyimages-pensive-investor-at-computer.jpg
Novavax Stock Just Tripled. Is It Too Late to Buy?

After losing more than 90% of its value from a peak back in 2021, Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two trading sessions after announcing a $1.2 billion

Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?: https://g.foolcdn.com/editorial/images/777124/wall-street-analyst-with-laptop-getty.jpg
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?

Shares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday, May 10. The market was responding to terrific news from Sanofi (NASDAQ: SNY), a global

Why Novavax Stock More Than Doubled Today: https://g.foolcdn.com/editorial/images/776909/break-through-ceiling.jpg
Why Novavax Stock More Than Doubled Today

Shares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report, however, driving the bulk of today's oversize

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole: https://g.foolcdn.com/editorial/images/774362/doctor-vaccinating-a-patient.jpg
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

The market isn't rational always and everywhere. Sometimes, shares of excellent companies with bright futures almost inexplicably fail to keep pace with broader equities. When that happens, it's

Better Buy: Bluebird Bio Vs. Novavax: https://g.foolcdn.com/editorial/images/772574/physician-giving-a-high-five-to-a-young-patient.jpg
Better Buy: Bluebird Bio Vs. Novavax

If there is one thing Bluebird Bio (NASDAQ: BLUE) and Novavax (NASDAQ: NVAX) have in common, other than their belonging to the biotech industry, it is that both have seen their shares drop

Down 60% From Its 52-Week High, Is Novavax Stock a Buy?: https://g.foolcdn.com/editorial/images/772085/stock-traders-looking-at-a-chart.jpg
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?

In just the past 12 months, Novavax (NASDAQ: NVAX) stock has plummeted 48% in value. The once-promising COVID vaccine maker has struggled mightily; it was late to getting a vaccine approved and to

1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague: https://g.foolcdn.com/editorial/images/771003/physician-on-a-virtual-consultation-with-patient.jpg
1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague

Sometimes it is worth it to buy shares of companies on the dip, and sometimes it isn't. It all depends on whether there are good reasons to believe the company in question will bounce back, and if

Is Novavax a Buy Now?: https://g.foolcdn.com/editorial/images/767610/gettyimages-1150572051.jpg
Is Novavax a Buy Now?

Novavax (NASDAQ: NVAX) has taken investors on a roller coaster ride over the past week or so. The stock soared after the company settled a dispute with a big customer, then sank as it reported

1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?: https://g.foolcdn.com/editorial/images/766670/scientist-conducting-an-experiment-in-a-lab.jpg
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?

Since 2021, shares of Novavax (NASDAQ: NVAX) have absolutely crumbled, falling by a whopping 95%. Even with the price rally in recent days, the stock has still been a disastrous investment over the

Has Novavax Just Solved Its Biggest Problem?: https://g.foolcdn.com/editorial/images/766803/gettyimages-1295271909.jpg
Has Novavax Just Solved Its Biggest Problem?

Many investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the revenue opportunities ahead of it. Once one of

Where Will Novavax Be in 10 Years?: https://g.foolcdn.com/editorial/images/763753/nurse-in-ppe-loads-syringe.jpg
Where Will Novavax Be in 10 Years?

After a brutal three-year period that saw its shares collapse by 99%, any remaining longtime shareholders of Novavax (NASDAQ: NVAX) are doubtlessly eager for the biotech to finally step out of the

Better Recovery Story Buy: Novavax vs. Teladoc: https://g.foolcdn.com/editorial/images/763364/gettyimages-1199696916.jpg
Better Recovery Story Buy: Novavax vs. Teladoc

Everybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that means you could win big each time this player

Could Novavax Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/763219/gettyimages-103919680.jpg
Could Novavax Stock Help You Become a Millionaire?

Novavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting on this biotech company making it to the

1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell: https://g.foolcdn.com/editorial/images/762662/worker-holds-coronavirus-vaccine-syringe.jpg
1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell

Like many of the biotechs pursuing coronavirus vaccine development, Novavax (NASDAQ: NVAX) has seen better days. Its shares are down by 96% over the past three years, and the company's remaining

1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell: https://g.foolcdn.com/editorial/images/762839/gettyimages-1295986889.jpg
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell

Novavax (NASDAQ: NVAX) shares have offered investors a roller coaster ride over the past few years. They soared more than 2,700% in early pandemic days as investors bet on the company's

Is It Too Late to Buy Novavax Stock?: https://g.foolcdn.com/editorial/images/762426/doctor-vaccinating-a-patient.jpg
Is It Too Late to Buy Novavax Stock?

A few years ago, biotech company Novavax (NASDAQ: NVAX) looked like a promising stock. It emerged as a leader in the development of a COVID-19 vaccine, which sent its share price through the roof.

Where Will Novavax Be in 5 Years?: https://g.foolcdn.com/editorial/images/762089/a-person-receiving-a-vaccine-from-a-nurse.jpg
Where Will Novavax Be in 5 Years?

There was a lot of promise around Novavax (NASDAQ: NVAX) and its COVID vaccine a few years ago. But with the company being late to the finish line and now generating limited revenue from the

Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?: https://g.foolcdn.com/editorial/images/762140/gettyimages-1295271909.jpg
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?

Novavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability to bring a coronavirus vaccine to market. The company followed through on that -- but not as

Is Novavax Stock a Buy Now?: https://g.foolcdn.com/editorial/images/756002/person-getting-vaccinated.jpg
Is Novavax Stock a Buy Now?

Biotech company Novavax (NASDAQ: NVAX) went from being relatively unknown just four years ago to becoming one of the U.S. COVID-19 vaccine market leaders. The company has faced many trials and

Novavax’s dispute resolution and upcoming earnings call: https://www.marketbeat.com/logos/articles/med_20240222142457_novavaxs-dispute-resolution-and-upcoming-earnings.jpg
Novavax’s dispute resolution and upcoming earnings call

Novavax (NASDAQ: NVAX) is a biotechnology pioneer dedicated to developing innovative vaccines against serious infectious diseases. Their unique approach utilizes protein-based technology, an